Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | Haematologica - the Hematology journal |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552932278927360 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Haematologica - the Hematology journal |
| description | |
| discipline_display | Hematology |
| discipline_facet | Hematology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:69087 |
| institution | FRELIP |
| journal_source_facet | Haematologica - the Hematology journal |
| last_indexed | 2026-06-20T21:28:52.253Z |
| publishDate | 2025 |
| publishDateSort | 2025 |
| record_format | rss_article |
| spellingShingle | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication Hematology General Hematology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Hematology General Hematology |
| subject_facet | Hematology General Hematology |
| title | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_alt | Ensayo de fase II aleatorizado multicéntrico inicial de quizartinib y citarabina en dosis altas más mitoxantrona en leucemia mieloide aguda recidivante/refractaria con duplicación interna en tándem de tirosina quinasa tipo FMS Essai de phase II randomisé multicentrique upfront de quizartinib et de cytarabine haute dose plus mitoxantrone dans la leucémie aiguë myéloïde réfractaire/récidivante avec duplication interne en tandem de FMS-like tyrosine kinase 3 Ensaio randomizado multicêntrico de fase II upfront de quizartinibe e citarabina em altas doses mais mitoxantrona na leucemia mieloide aguda recidivada/refratária com duplicação interna em tandem do receptor tirosina quinase tipo FMS 3 |
| title_auth | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_es_txt | Ensayo de fase II aleatorizado multicéntrico inicial de quizartinib y citarabina en dosis altas más mitoxantrona en leucemia mieloide aguda recidivante/refractaria con duplicación interna en tándem de tirosina quinasa tipo FMS |
| title_fr_txt | Essai de phase II randomisé multicentrique upfront de quizartinib et de cytarabine haute dose plus mitoxantrone dans la leucémie aiguë myéloïde réfractaire/récidivante avec duplication interne en tandem de FMS-like tyrosine kinase 3 |
| title_full | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_fullStr | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_full_unstemmed | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_pt_txt | Ensaio randomizado multicêntrico de fase II upfront de quizartinibe e citarabina em altas doses mais mitoxantrona na leucemia mieloide aguda recidivada/refratária com duplicação interna em tandem do receptor tirosina quinase tipo FMS 3 |
| title_short | Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication |
| title_sort | multicenter upfront randomized phase ii trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with fmslike tyrosine kinase 3 internal tandem duplication |
| topic | Hematology General Hematology |
| url | https://haematologica.org/article/view/13000 |